The MSLT-1 study compared sentinel lymph node biopsy (SLNB) with nodal observation in patients with localized cutaneous melanoma. The final results of the trial—conducted from 1994 to 2002—strongly support using SLNB in staging patients with melanomas ≥1.0 mm in thickness, but the optimal staging approach for thinner melanomas is unanswered.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Morton, D. L. et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 127, 392–399 (1992).
Thomas, J. M. Prognostic false-positivity of the sentinel node in melanoma. Nat. Clin. Pract. Oncol. 5, 18–23 (2008).
McMasters, K. M. et al. Lessons learned from the Sunbelt Melanoma Trial. J. Surg. Oncol. 86, 212–223 (2004).
Morton, D. L. et al. Sentinel-node biopsy or nodal observation in melanoma. N. Engl. J. Med. 355, 1307–1317 (2006).
Morton, D. L. et al. Final report of sentinel-node biopsy versus nodal observation in melanoma. N. Engl. J. Med. 370, 599–609 (2014).
Faries, M. B. et al. The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I). Ann. Surg. Oncol. 17, 3324–3329 (2010).
Balch, C. M. The role of elective lymph node dissection in melanoma: rationale, results, and controversies. J. Clin. Oncol. 6, 163–172 (1988).
Han, D. et al. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma. J. Clin. Oncol. 31, 4387–4393 (2013).
Gershenwald, J. E., Coit, D. G., Sondak, V. K. & Thompson, J. F. The challenge of defining guidelines for sentinel lymph node biopsy in patients with thin primary cutaneous melanomas. Ann. Surg. Oncol. 19, 3301–3303 (2012).
Wong, S. L. et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. J. Clin. Oncol. 30, 2912–2918 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
V.K.S. is a consultant for Bristol–Myers Squibb, Glaxo Smith-Kline, Merck, Navidea, Novartis and Provectus. J.S.Z. is a consultant for Amgen and Delcath Systems.
Rights and permissions
About this article
Cite this article
Sondak, V., Zager, J. MSLT-1—putting sentinel lymph node biopsy into context. Nat Rev Clin Oncol 11, 246–248 (2014). https://doi.org/10.1038/nrclinonc.2014.66
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2014.66
This article is cited by
-
MSLT-I—response of clinical trial investigators
Nature Reviews Clinical Oncology (2014)